Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 52.30
+7.30 (16.22%)
At close: Aug 4, 2026
Acrobiosystems Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 887.21 | 838.12 | 645.02 | 543.65 | 474.43 | 384.99 |
Revenue Growth | 29.42% | 29.94% | 18.65% | 14.59% | 23.23% | 56.30% |
Gross Profit Gross Profit Growth | 743.92 | 699.57 | 546.78 | 458.52 | 415.42 | 350.72 |
Operating Income Operating Income Growth | 133.44 | 117.7 | 59.48 | 78.67 | 116.3 | 173.63 |
Net Income Net Income Growth | 171.25 | 165.57 | 123.83 | 153.59 | 203.73 | 174.21 |
Earnings Per Share EPS Growth | 1.04 | 0.99 | 0.74 | 0.91 | 1.21 | 1.31 |
EPS Growth | 32.36% | 33.99% | -19.31% | -24.58% | -7.44% | 42.43% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Research and Experimental Development Research and Experimental Development Growth | 872.65 | 823.56 | 632.94 | 532.8 | 466.58 | 376.71 |
Unallocated Others Unallocated Others Growth | - | 14.56 | 12.09 | 10.85 | 7.85 | 8.28 |
Total Total Growth | 887.21 | 838.12 | 645.02 | 543.65 | 474.43 | 384.99 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,315 | 1,346 | 1,888 | 1,987 | 2,074 | 2,278 |
Total Debt Total Debt Growth | 82.55 | 86.4 | 140.71 | 64.61 | 71.49 | 29.38 |
Net Cash (Debt) Net Cash Growth | 1,232 | 1,259 | 1,747 | 1,922 | 2,002 | 2,249 |
Net Cash Growth | -28.18% | -27.94% | -9.08% | -4.00% | -10.98% | 2034.69% |
Net Cash Per Share Net Cash Per Share Growth | 7.48 | 7.52 | 10.41 | 11.44 | 11.91 | 16.91 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 362.22 | 355.74 | 84.71 | 111.2 | 202.19 | 138.01 |
Capital Expenditures CapEx Growth | -221.4 | -205.08 | -167.26 | -128.69 | -284.29 | -61.7 |
Free Cash Flow Free Cash Flow Growth | 140.82 | 150.66 | -82.56 | -17.49 | -82.1 | 76.31 |
Free Cash Flow Growth | - | - | - | - | - | -6.39% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 83.85% | 83.47% | 84.77% | 84.34% | 87.56% | 91.10% |
Operating Margin | 15.04% | 14.04% | 9.22% | 14.47% | 24.51% | 45.10% |
Pretax Margin | 19.76% | 20.20% | 19.37% | 29.55% | 45.31% | 50.77% |
Profit Margin | 19.30% | 19.75% | 19.20% | 28.25% | 42.94% | 45.25% |
FCF Margin | 15.87% | 17.98% | -12.80% | -3.22% | -17.30% | 19.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.600 | 0.600 | 0.500 | 0.643 | 0.714 | 0.714 |
Dividend Per Share Growth | -2.33% | 20.00% | -22.23% | -10.00% | 0% | - |
Dividend Yield | 1.33% | 1.13% | 1.63% | 1.61% | 1.57% | 0.77% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 50.34 | 54.60 | 42.68 | 46.04 | 40.32 | 96.95 |
Forward PE | 30.23 | 32.73 | 33.67 | 31.34 | 33.13 | 53.96 |
P/FCF Ratio | 62.09 | 60.00 | - | - | - | 221.35 |
PS Ratio | 9.85 | 10.79 | 8.19 | 13.01 | 17.32 | 43.87 |